Expertise

Multum and its parent company, Cerner Corporation, are healthcare information companies - not publishers. All of Multum’s content is developed in-house by our full-time staff of physicians, pharmacists, and software engineers, whose collective expertise creates products that contain the most current and comprehensive drug information possible. Multum's staff of software development engineers creates and maintains our internal systems for content authorship and production.

Our researchers rely primarily on analysis of primary medical literature. They also review secondary sources that include manufacturer’s package labeling as well as prominent review articles, textbook sources and FDA announcements. Our drug lexographers also use electronic links to drug wholesalers and manufacturers for such information as new drug products, proprietary names, and pricing.

Multum’s drug information is not licensed from any other source. As a result, our products maintain a degree of internal consistency attained by few other drug information vendors.

External Review

All clinical information generated in-house is distributed to clinical experts from Multum’s independent staff of medical reviewers. The reviewers are practicing clinicians representing all major medical and surgical disciplines involved in pharmacotherapy. Information is distributed to reviewers electronically on a closed web-based network that allows rapid and collaborative review of clinical topics before release of new information to our clients.

Patented Patient - Specific Methodology

Multum is the only organization that can provide patient specific dosing modules based on individual patient characteristics. We own patents to the methodology used to derive patient specific dosing and ordering based on characteristics such as age, height, weight, liver function, and kidney function.

Home  Products  Client Support